Abstract Title:

Effect of Statins on Serum Prostate-specific Antigen Levels.

Abstract Source:

Urology. 2010 Nov;76(5):1048-51. PMID: 20605197

Abstract Author(s):

Bulent Akduman, Daniel J Tandberg, Colin I O'Donnell, Alexa Hughes, Mark A Moyad, E David Crawford

Article Affiliation:

Department of Urology, Zonguldak Karaelmas University, School of Medicine, Zonguldak, Turkey. [email protected]

Abstract:

OBJECTIVES: The use of statins, which are cholesterol-lowering drugs, has increased significantly during the last decade. In this study, we investigate the effect of statins on serum prostate-specific antigen (PSA) levels in men participating in a prostate cancer screening event.

METHODS: A cohort of 4903 men who participated in Prostate Cancer Awareness Week in the years 2007 or 2008 were enrolled in this study from multiple clinical institutions. Within this cohort 1379 men (28.2%) were on a statin medication. Serum PSA, total testosterone, and total cholesterol were compared between the cohort of men using statins and the cohort of men who did not indicate current statin use. In multivariate regression analysis we controlled for age, body mass index (BMI), and race.

RESULTS: The mean age of the population was 60.7 years. Serum testosterone levels in patients on statin medication were significantly lower than in patients not on statins (P<.001). Mean total cholesterol levels were similar between the 2 groups (P = .229). Mean serum PSA level was 1.56 ng/mL in patients on statin medication and 1.48 ng/mL in patients not on statin (P = .120). After adjusting for significant covariates (age, BMI, and race), statin use was shown to have a significant association with lower mean PSA (P = .008) and lower mean testosterone (P<.001) and similar total cholesterol (P = .083).

CONCLUSIONS: Although use of statins may lower serum PSA levels, its clinical impact is limited. It may not be necessary to determine a different PSA cutoff level for patients on statin medication.

Study Type : Human Study
Additional Links
Adverse Pharmacological Actions : Endocrine Disruptor : CK(527) : AC(105)

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.